Commentary

S Liu et al. recently launched interesting concepts on how microRNAs (miRNAs) can control the gut microbiome. One paper by Liu and Weiner, Control of the gut microbiome by fecal microRNA, was published in Microbial Cell 2016; 3: 176 7; another by Liu S, da Cunha AP, Rezende RM, Wei Z, Bry L, Comstock LE, et al., The host shapes the gut microbiota via fecal micoRNA appeared in Cell Host Microbe 2016; 19: 32 43. A commentary to these papers is given here. MicroRNAs (miRNAs), detected in the early 1990s, are small non-coding RNAs, 18 23 nucleotides in length. They are synthesized in the nucleus and are processed and function in the cytoplasm. miRNAs can also exist extracellularly and circulate in body fluids. They have mainly been associated with the posttranscriptional regulation of gene expression on a cell-autonomous level. Recently, Liu and Weiner (1) and Liu et al. (2) described miRNAs in the gut lumen and feces of both humans and mice. The two main sources of fecal miRNAwere intestinal epithelial cells (IEC) and Hopx-expressing cells (mice). The most abundant miRNAs in feces were present in an extracellular vesicle form. Interestingly, a deficiency of IEC-miRNA caused gut dysbiosis, but wild-type fecal miRNA transplantation restored the gut microbiota. Most noteworthy, the researchers found that miRNAs were able to regulate the gut microbiome. By culturing bacteria together with miRNAs, they observed that the miRNAs of the host were able to enter bacteria, such as Fusobacterium nucleatum and Escherichia coli, and co-localize with bacterial nucleic acids. miRNAs specifically regulated gene transcripts and influenced bacterial growth. However, there was a different capability of miRNAs to enter bacteria, and this might explain different miRNA effects on bacterial gene transcription and growth. Furthermore, the oral administration of synthetic miRNA mimicked specific bacteria affected in the gut. These findings describe hitherto unknown pathways by which the gut microbiome is regulated by the host. Oral administration also raises the possibility of miRNAs being used therapeutically to manipulate the gut microbiome in the treatment of disease. Last but not least, the research raises additional questions: Could the oral microbiota be regulated by miRNAs? and, in turn, Could miRNAs be used for treatment of oral diseases? It is well known that the gut contains a myriad of commensal microbes. Dysbiosis in this microbiome may have consequences for the development of the immune system; metabolism; and diseases, such as autoimmune disorders, autism, and cancer. It is therefore important to understand what regulates the gut microbiome and identify strategies to prevent gut diseases. miRNAs can exist extracellularly in the body and indicate specific diseases. The authors of ‘‘The host shapes the gut microbiota via fecal micoRNA’’ found that miRNAs were part of the feces in both humans and mice. miRNAs within feces were mainly produced by gut epithelial cells and Hopx cells (Fig. 1). The abundance of miRNAs was inversely correlated with the abundance of microbes, thus indicating that microbes might take up miRNAs from the host and that these miRNAs might in turn affect the microbes. When miRNAs from the host entered bacteria, they co-localized with bacterial nucleic acids, which provide the temporal and spatial basis for regulation of gene expression. All bacterial gene sequences examined were found to pair with different miRNAs. Transcripts of the bacterial genes were altered by miRNA treatment, which also affected bacterial growth. 16S rDNA sequencing indicated that IEC-specific miRNA knockout caused dysbiosis in the microbiota of the gut, which was accompanied by the aggravation of colitis in a dextran sulfate sodium model in mice. A deficiency in epithelial-originated miRNAs led to a more diverse gut microbiota and changed epithelial barrier integrity. Fecal miRNA transplantation restored the gut microbiota. ournal of ral icrobiology